company background image
EURI B

European Institute of Science NGM:EURI B Stock Report

Last Price

kr0.12

Market Cap

kr10.7m

7D

-31.3%

1Y

6.0%

Updated

29 Nov, 2022

Data

Company Financials
EURI B fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

EURI B Stock Overview

European Institute of Science AB manufactures and sells diagnostic assays for the clinical laboratory and point-of-care settings, and point-of-care instrumentation for diagnostic applications in Sweden.

European Institute of Science AB Competitors

Price History & Performance

Summary of all time highs, changes and price drops for European Institute of Science
Historical stock prices
Current Share Pricekr0.12
52 Week Highkr0.37
52 Week Lowkr0.02
Beta-0.086
1 Month Change241.67%
3 Month Change68.49%
1 Year Change6.03%
3 Year Change-30.51%
5 Year Change-63.93%
Change since IPO-95.44%

Recent News & Updates

Recent updates

What Does European Institute of Science's (NGM:EURI B) CEO Pay Reveal?

Dec 12
What Does European Institute of Science's (NGM:EURI B) CEO Pay Reveal?

Shareholder Returns

EURI BSE BiotechsSE Market
7D-31.3%-0.4%0.9%
1Y6.0%-27.5%-24.0%

Return vs Industry: EURI B exceeded the Swedish Biotechs industry which returned -27.5% over the past year.

Return vs Market: EURI B exceeded the Swedish Market which returned -24% over the past year.

Price Volatility

Is EURI B's price volatile compared to industry and market?
EURI B volatility
EURI B Average Weekly Movement80.3%
Biotechs Industry Average Movement7.8%
Market Average Movement7.4%
10% most volatile stocks in SE Market12.2%
10% least volatile stocks in SE Market4.6%

Stable Share Price: EURI B is more volatile than 90% of Swedish stocks over the past 3 months, typically moving +/- 80% a week.

Volatility Over Time: EURI B's weekly volatility has increased from 43% to 80% over the past year.

About the Company

FoundedEmployeesCEOWebsite
19902Kirstin Krizhttps://www.euris.org

European Institute of Science AB manufactures and sells diagnostic assays for the clinical laboratory and point-of-care settings, and point-of-care instrumentation for diagnostic applications in Sweden. It primarily focuses on the diagnostic assays and instrumentation for canine, feline, and equine animals. The company’s products include TurboReader point-of-care instruments that performs measurements using disposable cuvettes; Canine C-Reactive (CRP) TurboReader assays for the quantitative determination of Canine CRP in dog serum or plasma; Feline Hp (Haptoglobin) TurboReader assay for determining Hp in cat serum or plasma; Feline SAA TurboReader assay for the determination of serum amyloid A (SAA) in cat serum or plasma; and Equine SAA TurboReader assay for determining SAA in horse serum or plasma.

European Institute of Science AB Fundamentals Summary

How do European Institute of Science's earnings and revenue compare to its market cap?
EURI B fundamental statistics
Market Capkr10.68m
Earnings (TTM)-kr2.67m
Revenue (TTM)kr514.00k

20.8x

P/S Ratio

-4.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EURI B income statement (TTM)
Revenuekr514.00k
Cost of Revenuekr180.00k
Gross Profitkr334.00k
Other Expenseskr3.01m
Earnings-kr2.67m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.031
Gross Margin64.98%
Net Profit Margin-519.65%
Debt/Equity Ratio0.0%

How did EURI B perform over the long term?

See historical performance and comparison